Literature DB >> 8912472

Molecular biology of prostate cancer.

X B Shi1, P H Gumerlock, R W deVere White.   

Abstract

Carcinoma of the prostate (CaP) is a very prevalent tumor among men. However thus far, relatively little information is known about the molecular mechanisms involved in the development, progression and metastasis of this disease. This article reviews the current state of knowledge of five selected molecular aspects of human CaP: tumor suppressor genes, metastasis suppressor genes and related biological events (allelic loss and DNA methylation), oncogenes (including growth factors and their receptors), the anti-apoptosis gene BCL2, and the human androgen receptor gene (hAR). Alterations of these genes in structure and expression as well as the frequencies of these molecular events are discussed to synthesize an understanding of documented genetic alterations that occur in CaP and their possible relation to the biology of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912472     DOI: 10.1007/bf00184605

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  131 in total

1.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

2.  Expression of E-cadherin in primary and metastatic prostate cancer.

Authors:  L Cheng; M Nagabhushan; T P Pretlow; S B Amini; T G Pretlow
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

3.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.

Authors:  M Colombel; F Symmans; S Gil; K M O'Toole; D Chopin; M Benson; C A Olsson; S Korsmeyer; R Buttyan
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

4.  Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.

Authors:  R Sadasivan; R Morgan; S Jennings; M Austenfeld; P Van Veldhuizen; R Stephens; M Noble
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

5.  Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.

Authors:  J D Brooks; G S Bova; W B Isaacs
Journal:  Prostate       Date:  1995-01       Impact factor: 4.104

6.  Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

Authors:  Z Culig; A Hobisch; M V Cronauer; A C Cato; A Hittmair; C Radmayr; J Eberle; G Bartsch; H Klocker
Journal:  Mol Endocrinol       Date:  1993-12

Review 7.  Oncogenes in prostate cancer. An update.

Authors:  D M Peehl
Journal:  Cancer       Date:  1993-02-01       Impact factor: 6.860

8.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Authors:  W D Tilley; G Buchanan; T E Hickey; J M Bentel
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

9.  High levels of nm23 expression are related to cell proliferation in human prostate cancer.

Authors:  M Igawa; D B Rukstalis; T Tanabe; G W Chodak
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.

Authors:  M Chen; J Quintans; Z Fuks; C Thompson; D W Kufe; R R Weichselbaum
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

View more
  4 in total

Review 1.  Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

Authors:  Eduardo de Paula Nascente; Renée Laufer Amorim; Carlos Eduardo Fonseca-Alves; Veridiana Maria Brianezi Dignani de Moura
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

2.  Malignant phenotype of PC3 cell line was inhibited by siRNA targeting PAR gene.

Authors:  Xiaofeng Xu; Siwei Zhou; Zhengyu Zhang; Jingping Ge; Wen Cheng; Zhifeng Wei; Xu Zhang; Jianping Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

3.  Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.

Authors:  Adelaide Greco; Altomare Di Benedetto; Candace M Howard; Sarah Kelly; Rounak Nande; Yulia Dementieva; Michele Miranda; Arturo Brunetti; Marco Salvatore; Luigi Claudio; Devanand Sarkar; Paul Dent; David T Curiel; Paul B Fisher; Pier P Claudio
Journal:  Mol Ther       Date:  2009-11-03       Impact factor: 11.454

4.  Prognostic factors in prostate cancer.

Authors:  A Buhmeida; S Pyrhönen; M Laato; Y Collan
Journal:  Diagn Pathol       Date:  2006-04-03       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.